A detailed history of Allworth Financial LP transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 3,119 shares of RANI stock, worth $4,148. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,119
Previous 3,119 -0.0%
Holding current value
$4,148
Previous $11,000 45.45%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

SELL
$2.17 - $4.44 $6 - $13
-3 Reduced 0.1%
3,119 $6,000
Q1 2023

Apr 18, 2023

BUY
$5.07 - $6.89 $15 - $20
3 Added 0.1%
3,122 $16,000
Q4 2022

Jan 13, 2023

BUY
$5.51 - $10.02 $17,185 - $31,252
3,119 New
3,119 $0

Others Institutions Holding RANI

About Rani Therapeutics Holdings, Inc.


  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $32.6M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.